Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06455150
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-12
First Post:
2024-06-06
Brief Title:
Prevalence of Pelvic Floor Dysfunctions in Female Badminton Athletes and Sedentary
Sponsor:
University of Alcala
Organization:
University of Alcala
Study Overview
Official Title:
Prevalence of Pelvic Floor Dysfunctions in Female Badminton Athletes and Sedentary Protocol of an Observational Case-Control Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of the study is to know the prevalence of pelvic floor dysfunctions in female badminton athletes compared to sedentary women and the hypothesis is that the prevalence of pelvic floor dysfunctions is going to be higher in female badminton athletes
Detailed Description:
After being informed about the study all participants giving written informed consent will complete the personal data questionnaire and the questionnaires validated to Spanish population International Consultation on Incontinence Questionnaire-Short Form ICIQ-SF Pelvic Floor Distress Inventory Short Form PFDI-20 Female Sexual Function Index FSFI and the SF-12 questionnaire After that inclusion and exclusion criteria will be assessed and participants will be allocated into cases and controls group Both groups will undergo the same procedures Firstly the evaluation of stress urinary incontinence and pelvic organ prolapse signs will be performed by using the cough stress test and Pelvic Organ Prolapse Quantification System and secondly the evaluation of pelvic floor muscle strength by using manometry
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None